Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-23T17:50:25.103Z Has data issue: false hasContentIssue false
  • English
  • Français

Diagnosis and Prevention of Fragile-X Syndrome. From the Family Study to the Population Screening Programme: Eighteen Years of Activity

Published online by Cambridge University Press:  01 August 2014

M.L. Giovannucci Uzielli ,
S. Guarducci ,
A. Cecconi ,
S. Lenzi ,
U. Ricci ,
C. Balestrieri ,
P. Petrocelli  and
E. Lapi
M.L. Giovannucci Uzielli*
Affiliation:
Human Genetics Center, Department of Paediatrics, University of Florence, Italy
S. Guarducci
Affiliation:
Human Genetics Center, Department of Paediatrics, University of Florence, Italy
A. Cecconi
Affiliation:
Human Genetics Center, Department of Paediatrics, University of Florence, Italy
S. Lenzi
Affiliation:
Human Genetics Center, Department of Paediatrics, University of Florence, Italy
U. Ricci
Affiliation:
Human Genetics Center, Department of Paediatrics, University of Florence, Italy
C. Balestrieri
Affiliation:
Human Genetics Center, Department of Paediatrics, University of Florence, Italy
P. Petrocelli
Affiliation:
Human Genetics Center, Department of Paediatrics, University of Florence, Italy
E. Lapi
Affiliation:
Human Genetics Center, Department of Paediatrics, University of Florence, Italy
*
Human Genetics Center, Department of Paediatrics, University of Florence, Via Masaccio, 209, 50132 Firenze, Italy

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Fragile-X syndrome, which derives its name from the expression of a fragile site (FRAXA) at Xq27.3 associated with the phenotype, has achieved distinction as the most common inherited cause of mental retardation. It is the first disorder shown to be due to dynamic mutation in heritable instable DNA.

In 1991 the mutation responsible for Fragile-X syndrome was delineated as an expansion of the trinucleotide (CGG) sequence within an evolutionarily conserved gene, at the position of the fragile-X site.

The DNA of the promoter in the 5' UTR region of FMR-1 gene becomes abnormally methylated when the CGG sequence exceeds approximately 230 repeats, resulting in the transcriptional suppression of FMR-1. Based on the length of CGG repeat in the FMR-1 gene, the alleles are usually classified as normal, premutation or full mutation. CGG instability correlates with the length of repeats and number of AGGs within the FMR-1 CGG tract. In a minority of cases the Fragile-X syndrome may be due to deletion, or to point mutation in the FMR-1 gene.

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 45 , Issue 1-2 , April 1996 , pp. 303 - 308
Copyright
Copyright © The International Society for Twin Studies 1996

References

REFERENCES

1. Brown, WT, Houck, G, Jeziorowska, A, Levinson, F, Ding, X, Jenkins, EC: Rapid Fragile X Carrier Screening and Prenatal Diagnosis using a Nonradioactive PCR Test. JAMA 270, 1569–1575, 1993.CrossRefGoogle ScholarPubMed
2. Giraud, FA, Ayme, S, Mattei, JF, Mattel, MG: Constitutional chromosomal breakage. Hum Genet 34: 125–136, 1976.CrossRefGoogle ScholarPubMed
3. Hagerman, R, Berry, R, Jackson, A, Campbell, J: Institutional Screening for the Fragile X Syndrome. AJDC 142, 1216–1221, 1988.Google ScholarPubMed
4. Harvey, J, Judge, C, Wiener, S: Familial X-linked mental retardation with an X chromosome abnormality. J Med Genet 14: 46–50, 1977.CrossRefGoogle ScholarPubMed
5. Lubs, HA: A marker X chromosome. Am J Hum Genet 21: 231–244, 1969.Google Scholar
6. Rousseau, F, Robb, L, Rouillard, P, Der Kaloustian', V: No mental retardation in a man with 40% abnormal methylation at the FMR-1 locus and transmission of sperm cell mutations as premutations. Hum Mol Genet 3: 927–930, 1994.Google Scholar
7. Rousseau, F, Heitz, D, Biancalana, V, Oberle, I, Mandel, JL: On some Technical Aspects of Direct DNA Diagnosis of the Fragile X Syndrome. Am J Med Genet 43: 197–207, 1992.CrossRefGoogle ScholarPubMed
8. Rousseau, F. The fragile X syndrome: Implications of molecular genetics for the clinical syndrome. Eur J Clin Invest 24: 1–10, 1994.Google Scholar
9. Sutherland, GR: Fragile sites on human chromosomes; demonstration of their dependence on the type of tissue culture medium. Science 197: 265–266.Google Scholar
10. Tarleton, J, Saul, R: Molecular genetic advances in Fragile X syndrome. J Pediat 122: 169–185, 1993.Google Scholar
11. Turner, G, Robinson, H, Laing, S, Van Den Berk, M, Colley, A, Goddard, A, Sherman, S, Partington, M: Population Screening for fragile X. Lancet 339: 1210–1213, 1992.Google Scholar
12. van den Ouweland, A, Deelen, W, Kunst, C, Giovannucci Uzielli, ML, Nelson, D, Warren, S, Oostra, B, Halley, D: Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes. Hum Mol Genet 3, 1823–1827, 1994.Google Scholar
13. Wang, Q, Green, E, Barnicoat, A, Mathew, CG: Cytogenetic versus DNA diagnosis in routine referrals for Fragile X syndrome. Lancet 342: 1025–1026, 1993 Google Scholar
14. Wang, Q, Green, E, Bobrow, M, Mathew, CG: A rapid, non- radioactive screening test for fragile X mutationa at the FRAXA and FRAXE loci. J Med Genet 32: 170–173, 1995.Google Scholar